REDUCEIT reveals high dose of pure EPA in omega3 drug cuts risk of...
Brigham and Women's Hospital Results released today from a major clinical trial may have direct implications for patients who remain at increased cardiovascular risk despite taking statin therapy.
View ArticleDoctors overcorrect too often
Back when cholesterol target numbers ruled unopposed before 2013 we all checked fasting lipids every three months. Before 2012 we also checked liver function quarterly in hapless riders on the...
View ArticleNew Lipid Guidelines Address NonStatin Therapies Personalized Risk Assessment
The American Heart Association AHA and American College of Cardiology along with numerous other groups released updated guidelines on cholesterol management on Saturday. The recommendations...
View ArticleAmarin Corp Plc AMRN Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryAmarin Corp Plc Amarin is a biopharmaceutical company which develops and commercializes medicines for cardiovascular domain. The company's lead product Vascepa icosapent ethyl is a US FDA...
View ArticleHomozygous Familial Hypercholesterolemia HoFH Pipeline Review H2 2018 Report...
Homozygous Familial Hypercholesterolemia HoFH Pipeline Review H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Homozygous Familial Hypercholesterolemia...
View ArticleOnset of Musculoskeletal Adverse Events Varies Between Statins
MONDAY Nov. 19 2018 The onset of musculoskeletal adverse events MAEs during statin monotherapy is significantly faster with use of atorvastatin and rosuvastatin versus simvastatin according to a study...
View ArticleGlobal Statin Market 20192023 Rising in Prevalence of Hypercholesterolemia...
LONDON&8211;BUSINESS WIRE&8211;Research&8211;The global statin market 20192023 is expected to have an incremental growth of around $1647 million during the forecast period according to the...
View ArticleStatin Medications and the Risk of Gynecomastia
Is the use of statins associated with an increased risk of gynecomastia Clinical Endocrinology
View ArticleThe ODYSSEY OUTCOMES trial Alirocumab associated with reduced ischemic events...
1. Among patients that suffered a recent acute coronary syndrome ACS and had elevated levels of atherogenic lipoproteins despite intensive or maximumintensive statin therapy alirocumab reduced the...
View ArticleStatin Primary Prevention Tx Thresholds Should Be Raised Group Says
MedPage Today Computer modeling study suggests more nuance in riskbenefit ratio
View ArticleRecommended tenyear risk thresholds for statin prescriptions are too low...
Higher tenyear risk thresholds should be used when recommending statins for the primary prevention of cardiovascular disease study results have concluded.
View ArticleBefore Starting a Statin Talk It Over with Your Doctor
NPR &8211; A study published Monday is pushing back against the notion that up to 40 percent of Americans should be taking statin drugs to reduce the risk of heart disease. The study in the Annals...
View ArticleFirstyear statin discontinuation and nonadherence common in older adults
A substantial proportion of older people who begin taking statins do not take them as intended according to an Australian study published in theĆBritish Journal of Clinical Pharmacology.
View ArticleHigh intensity statin treatment and adherence could save more lives
Thousands of heart attacks and deaths from cardiovascular disease could be prevented by patients taking higher doses of statins and taking the drugs as advised by doctors.
View ArticleDec 7 2018 This Week in Cardiology
Measures of hospital quality statin under or overuse Botox for AF smoking cessation and translating trial evidence to clinical practice are discussed in this weeks podcast. theheart.org on Medscape
View ArticleModelling study suggests that statins may be overprescribed
1. This study showed that the net benefit of statins compared to risk varied considerably with respect to the age of the patient patient sex and the type of statin utilized. 2. This modeling study...
View ArticleStatins have low risk of side effects
American Heart Association Cholesterollowering statin drugs are associated with a low risk of side effects. The benefits of statin therapy for most people outweigh the risks.
View ArticleHeart Group Statins' Benefits "Greatly Outweigh" Their Risks
For most patients who meet criteria for statin therapy the benefits "greatly outweigh" the risks according to a new scientific statement from the American Heart...
View ArticleLiverRelated Effects of Statin Use in Patients with Primary Sclerosing...
Statin use may decrease mortality and liverrelated adverse events including liver transplantation in patients with PSC and inflammatory bowel disease.
View ArticleInto the Fray AHA's First Scientific Statement on Statin Safety
The benefits of statins outweigh the harms the report asserts which is likely to renew calls for the release of patientlevel data from industrysponsored statin trials for independent scrutiny. Medscape...
View Article